Tuesday, February 9, 2021

Pharma Reviews: Rhizen Pharma gets US FDA accelerated approval for Umbralisib (UKONIQ) to treat relapsed or ...

Swaroop Vakkalanka, President & CEO of Rhizen Pharmaceuticals said, “We are keen to bring Umbralisib to Indian patients and we plan to initiate ...
Read more: Rhizen Pharma gets US FDA accelerated approval for Umbralisib (UKONIQ) to treat relapsed or ...